Dyno
Dyno Therapeutics is an AI and biotechnology company building high-performance gene delivery technologies to unlock the potential of next-generation genetic medicine. Using its CapsidMap platform, which combines machine learning with high-throughput in vivo measurement, Dyno designs novel adeno-associated virus (AAV) capsids with improved tissue targeting, immune evasion, manufacturability, and payload capacity. The company partners with leading gene therapy developers rather than exposing a public developer API; it is tracked in the API Evangelist network as an a16z Bio+Health portfolio company. Founded on research from George Church's lab at Harvard, Dyno is headquartered in Watertown, Massachusetts.
Dyno is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Gene Therapy, Genetic Medicine, and Gene Delivery.
Dyno’s developer surface includes engineering blog and 4 more developer resources.
Kin Score
Security Posture 1
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Access & Security 1
Authentication, authorization, and security posture
Commercial 2
Pricing, plans, and the legal terms of use
Company 2
The organization behind the API